134 related articles for article (PubMed ID: 17279284)
1. Langerhans cell histiocytosis: a 16-year experience.
Campos MK; Viana MB; de Oliveira BM; Ribeiro DD; Silva CM
J Pediatr (Rio J); 2007; 83(1):79-86. PubMed ID: 17279284
[TBL] [Abstract][Full Text] [Related]
2. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
3. Egyptian experience in Langerhans cells histiocytosis: frequent multisystem affection and reactivation rates.
Tantawy AAG; Ragab IA; Elsherif NHK; Makkeyah SM; AbdelRaheem HG; Elsantiel HIE
Pediatr Hematol Oncol; 2020 Nov; 37(8):696-706. PubMed ID: 32706277
[No Abstract] [Full Text] [Related]
4. [Clinical study of 131 children with multi-system Langerhans cell histiocytosis].
Wu FF; Gao YJ; Pan C; Chen J; Tang JY
Zhonghua Er Ke Za Zhi; 2016 May; 54(5):349-53. PubMed ID: 27143076
[TBL] [Abstract][Full Text] [Related]
5. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
6. Langerhans cell histiocytosis: 23 years' paediatric experience highlights severe long-term sequelae.
Martin A; Macmillan S; Murphy D; Carachi R
Scott Med J; 2014 Aug; 59(3):149-57. PubMed ID: 24996784
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and survival of children with langerhans cell hystiocytosis].
Krstovski N; Janić D; Dokmanović L; Brdar R
Srp Arh Celok Lek; 2008; 136(9-10):514-8. PubMed ID: 19069343
[TBL] [Abstract][Full Text] [Related]
8. A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group.
Arch Dis Child; 1996 Jul; 75(1):17-24. PubMed ID: 8813865
[TBL] [Abstract][Full Text] [Related]
9. Langerhans cell histiocytosis in children less than 2 years of age.
Kusuma Kumary P; Priyakumari T; Chellam VG; James FV; Nair MK
Indian Pediatr; 1999 Jan; 36(1):29-36. PubMed ID: 10709120
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
Lee JW; Shin HY; Kang HJ; Kim H; Park JD; Park KD; Kim HS; Park SH; Wang KC; Ahn HS
Pediatr Hematol Oncol; 2014 Apr; 31(3):293-302. PubMed ID: 24397251
[TBL] [Abstract][Full Text] [Related]
11. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
Willis B; Ablin A; Weinberg V; Zoger S; Wara WM; Matthay KK
J Clin Oncol; 1996 Jul; 14(7):2073-82. PubMed ID: 8683239
[TBL] [Abstract][Full Text] [Related]
12. Predictors of outcome in children with Langerhans cell histiocytosis.
Jubran RF; Marachelian A; Dorey F; Malogolowkin M
Pediatr Blood Cancer; 2005 Jul; 45(1):37-42. PubMed ID: 15768381
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution.
Braier J; Chantada G; Rosso D; Bernaldez P; Amaral D; Latella A; Balancini B; Masautis A; Goldberg J
Pediatr Hematol Oncol; 1999; 16(5):377-85. PubMed ID: 10505313
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.
Gadner H; Heitger A; Grois N; Gatterer-Menz I; Ladisch S
Med Pediatr Oncol; 1994; 23(2):72-80. PubMed ID: 8202045
[TBL] [Abstract][Full Text] [Related]
15. Langerhans cell histiocytosis--a 31 year review.
Leavey P; Varughese M; Breatnach F; O'Meara A
Ir J Med Sci; 1991 Sep; 160(9):271-4. PubMed ID: 1769807
[TBL] [Abstract][Full Text] [Related]
16. [Clinical manifestations of Langerhans cell histiocytosis with multisystem involvement in 53 children].
Tang JJ; Xu XJ; Wang YC; Bai ST; Wang L; Ni XL; Liu YF
Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):37-41. PubMed ID: 33397002
[No Abstract] [Full Text] [Related]
17. [Clinical features and prognosis of Langerhans cell histiocytosis in children: an analysis of 34 cases].
Li D; Li H; Shi H
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jun; 19(6):627-631. PubMed ID: 28606227
[TBL] [Abstract][Full Text] [Related]
18. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
Chellapandian D; Shaikh F; van den Bos C; Somers GR; Astigarraga I; Jubran R; Degar B; Carret AS; Mandel K; Belletrutti M; Dix D; Visser J; Abuhadra N; Chang T; Rollins B; Whitlock J; Weitzman S; Abla O
Pediatr Blood Cancer; 2015 Dec; 62(12):2162-6. PubMed ID: 26179251
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and outcomes of adult Langerhans cell histiocytosis: a single-center experience.
Kobayashi M; Ando S; Kawamata T; Makiyama J; Yokoyama K; Imai Y; Tojo A
Int J Hematol; 2020 Aug; 112(2):185-192. PubMed ID: 32514929
[TBL] [Abstract][Full Text] [Related]
20. Treatment Outcome of Children With Multisystem Langerhans Cell Histiocytosis: The Experience of a Single Children's Hospital in Shanghai, China.
Gao YJ; Su M; Tang JY; Pan C; Chen J
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e9-e12. PubMed ID: 29200145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
